Backs FY25 adjusted EBITDA view $41M.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCAT:
- Health Catalyst Stockholders Approve Key Governance Changes
- Health Catalyst: Undervalued Stock with Promising Growth Potential and Strong Revenue Visibility
- Health Catalyst downgraded to Neutral from Buy at BTIG